Sign in / Join Now
ETFs & Funds
Justin M. Hall
) Giving up.
needs to get their stuff together. Collaboration this year, next? Good drug, but disappointed with team behind it.
Add a reply...
Latest StockTalks »
people get MATN breaking news and analysis by email alert.
Get email alerts on MATN »
Mateon Therapeutics, Inc.
Get latest price
From other sites
Mateon Therapeutics To Present Data On Study OX4218 In Neuroendocrine Tumors At ASCO Gastrointestinal Cancers Symposium
at TheStreet (Fri, 8:00AM)
OTC Markets Group Welcomes Mateon Therapeutics To OTCQX
at TheStreet (Dec 8, 2016)
Mateon Therapeutics, Inc. (MATN: OTCQX U.S.) | Venue Change
at otcmarkets.com (Dec 8, 2016)
Mateon Common Stock To Trade On OTCQX Beginning On December 8, 2016
at TheStreet (Dec 7, 2016)
Mateon Announces Presentation Of OXi4503 AML Study Data At 58th Annual Meeting Of American Society Of Hematology
at TheStreet (Dec 6, 2016)